Growing community of inventors

Stuttgart, Germany

Nico Trautwein

Average Co-Inventor Count = 9.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Nico TrautweinDaniel Johannes Kowalewski (10 patents)Nico TrautweinHans-Georg Rammensee (10 patents)Nico TrautweinStefan Stevanovic (10 patents)Nico TrautweinJuliane Sarah Walz (10 patents)Nico TrautweinSebastian Haen (10 patents)Nico TrautweinMoreno Di Marco (10 patents)Nico TrautweinAnnika Nelde (10 patents)Nico TrautweinMarkus Loeffler (9 patents)Nico TrautweinMarkus Löffler (1 patent)Nico TrautweinNico Trautwein (10 patents)Daniel Johannes KowalewskiDaniel Johannes Kowalewski (159 patents)Hans-Georg RammenseeHans-Georg Rammensee (68 patents)Stefan StevanovicStefan Stevanovic (51 patents)Juliane Sarah WalzJuliane Sarah Walz (25 patents)Sebastian HaenSebastian Haen (10 patents)Moreno Di MarcoMoreno Di Marco (10 patents)Annika NeldeAnnika Nelde (10 patents)Markus LoefflerMarkus Loeffler (9 patents)Markus LöfflerMarkus Löffler (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Immatics Biotechnologies Gmbh (10 from 727 patents)


10 patents:

1. 11559550 - Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers

2. 11560405 - Peptides and combination thereof for use in the immunotherapy against cancers

3. 11542303 - Peptides and combination thereof for use in the immunotherapy against cancers

4. 11427614 - Peptides and combination thereof for use in the immunotherapy against cancers

5. 11135246 - Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers

6. 11103534 - Peptides and combination thereof for use in the immunotherapy against cancers

7. 11020432 - Peptides and combination thereof for use in the immunotherapy against cancers

8. 11007223 - Peptides and combination thereof for use in the immunotherapy against cancers

9. 10993963 - Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers

10. 10899819 - Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/22/2026
Loading…